Back
Zynex, Inc. 10K Form
Sell
26
ZYXI
Zynex, Inc.
Last Price:
$1.04
Seasonality Move:
4.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-07-28 | 10Q | ZYXI/Zynex, Inc. Quarterly |
| 2020-04-28 | 10Q | ZYXI/Zynex, Inc. Quarterly |
| 2020-02-27 | 10K | ZYXI/Zynex, Inc. Annual |
| 2019-10-29 | 10Q | ZYXI/Zynex, Inc. Quarterly |
| 2019-07-31 | 10Q | ZYXI/Zynex, Inc. Quarterly |
| 2019-04-30 | 10Q | ZYXI/Zynex, Inc. Quarterly |
Receive ZYXI News And Ratings
See the #1 stock for the next 7 days that we like better than ZYXI
ZYXI Financial Statistics
Sales & Book Value
| Annual Sales: | $192.4M |
|---|---|
| Cash Flow: | $-6.3M |
| Price / Cash Flow: | 4.47 |
| Annual Sales: | $-1.36 |
| Price / Book: | 10.12 |
Profitability
| EPS (TTM): | -2.42600 |
|---|---|
| Net Income (TTM): | $-74M |
| Gross Margin: | $152.9M |
| Return on Equity: | -709.17% |
| Return on Assets: | -75.59% |
Zynex, Inc. Earnings Forecast
Key Zynex, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for ZYXI is 79.50%.
-
The Selling, General & Administrative Expenses for ZYXI have been equal to 76.39% of Gross Profit Margin.
-
The Research & Development expenses have been 6.24% of Revenue.
-
The Interest Expense is 79.56% of Operating Income.
-
The Net Earning history of ZYXI is 1.56% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 14 years.
Zynex, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | ZYXI |
| CUSIP: | 98986M |
| Website: | zynex.com |
Debt
| Debt-to-Equity Ratio: | -1.73 |
|---|---|
| Current Ratio: | 0.47 |
| Quick Ratio: | 0.25 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.51 |
|---|---|
| Forward P/E Ratio: | 8.05 |
ZYXI Technical Analysis vs Fundamental Analysis
Sell
26
Zynex, Inc. (ZYXI)
is a Sell
Is Zynex, Inc. a Buy or a Sell?
-
Zynex, Inc. stock is rated a SellThe current Zynex, Inc. [ZYXI] share price is $1.16. The Score for ZYXI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.